共 50 条
- [21] Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid TumorsMOLECULAR CANCER THERAPEUTICS, 2021, 20 (10) : 1988 - 1995Gordon, Michael S.论文数: 0 引用数: 0 h-index: 0机构: HonorHlth Res Inst, 10510 N 92nd St,Ste 200, Scottsdale, AZ 85258 USA HonorHlth Res Inst, 10510 N 92nd St,Ste 200, Scottsdale, AZ 85258 USANemunaitis, John论文数: 0 引用数: 0 h-index: 0机构: Univ Toledo, Coll Med & Life Sci, Dept Med, 2801 W Bancroft St, Toledo, OH 43606 USA ProMed Hlth Syst, Toledo, OH USA HonorHlth Res Inst, 10510 N 92nd St,Ste 200, Scottsdale, AZ 85258 USABarve, Minal论文数: 0 引用数: 0 h-index: 0机构: Mary Crowley Canc Res, Dallas, TX USA HonorHlth Res Inst, 10510 N 92nd St,Ste 200, Scottsdale, AZ 85258 USAWainberg, Zev A.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, UCLA Hlth, Ronald Reagan UCLA Med Ctr, Sch Med, Los Angeles, CA USA HonorHlth Res Inst, 10510 N 92nd St,Ste 200, Scottsdale, AZ 85258 USAHamilton, Erika P.论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Res Inst & Tennessee Oncol, Nashville, TN USA HonorHlth Res Inst, 10510 N 92nd St,Ste 200, Scottsdale, AZ 85258 USARamanathan, Ramesh K.论文数: 0 引用数: 0 h-index: 0机构: HonorHlth Res Inst, 10510 N 92nd St,Ste 200, Scottsdale, AZ 85258 USA HonorHlth Res Inst, 10510 N 92nd St,Ste 200, Scottsdale, AZ 85258 USASledge, George W., Jr.论文数: 0 引用数: 0 h-index: 0机构: Stanford Med, Stanford Canc Inst, Stanford, CA USA HonorHlth Res Inst, 10510 N 92nd St,Ste 200, Scottsdale, AZ 85258 USAYue, Huibin论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Oncol Early Dev, Redwood City, CA USA HonorHlth Res Inst, 10510 N 92nd St,Ste 200, Scottsdale, AZ 85258 USAMorgan-Lappe, Susan E.论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Translat Oncol, N Chicago, IL USA HonorHlth Res Inst, 10510 N 92nd St,Ste 200, Scottsdale, AZ 85258 USABlaney, Martha论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Oncol Early Dev, Redwood City, CA USA HonorHlth Res Inst, 10510 N 92nd St,Ste 200, Scottsdale, AZ 85258 USAKasichayanula, Sreeneeranj论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Oncol Early Dev, Redwood City, CA USA HonorHlth Res Inst, 10510 N 92nd St,Ste 200, Scottsdale, AZ 85258 USAMotwani, Monica论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Translat Oncol, N Chicago, IL USA HonorHlth Res Inst, 10510 N 92nd St,Ste 200, Scottsdale, AZ 85258 USAWang, Lan论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Oncol Early Dev, Redwood City, CA USA HonorHlth Res Inst, 10510 N 92nd St,Ste 200, Scottsdale, AZ 85258 USANaumovski, Louie论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, Oncol Early Dev, Redwood City, CA USA HonorHlth Res Inst, 10510 N 92nd St,Ste 200, Scottsdale, AZ 85258 USAStrickler, John H.论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Sch Med, Dept Med, Div Med Oncol, Durham, NC 27706 USA HonorHlth Res Inst, 10510 N 92nd St,Ste 200, Scottsdale, AZ 85258 USA
- [22] PHASE 1 STUDY EVALUATING THE SAFETY AND PHARMACOKINETICS OF PANITUMUMAB IN CHILDREN WITH SOLID TUMORSPEDIATRIC BLOOD & CANCER, 2016, 63 : S67 - S67Weigel, Brenda论文数: 0 引用数: 0 h-index: 0机构: Univ Minnesota, Minneapolis, MN USA Univ Minnesota, Minneapolis, MN USABanerjee, Anuradha论文数: 0 引用数: 0 h-index: 0机构: Univ Minnesota, Minneapolis, MN USA Univ Minnesota, Minneapolis, MN USAMeany, Holly论文数: 0 引用数: 0 h-index: 0机构: Univ Minnesota, Minneapolis, MN USA Univ Minnesota, Minneapolis, MN USAMalempati, Suman论文数: 0 引用数: 0 h-index: 0机构: Univ Minnesota, Minneapolis, MN USA Univ Minnesota, Minneapolis, MN USAFangusaro, Jason论文数: 0 引用数: 0 h-index: 0机构: Univ Minnesota, Minneapolis, MN USA Univ Minnesota, Minneapolis, MN USAZhang, Ying论文数: 0 引用数: 0 h-index: 0机构: Univ Minnesota, Minneapolis, MN USA Univ Minnesota, Minneapolis, MN USAOu, Ying论文数: 0 引用数: 0 h-index: 0机构: Univ Minnesota, Minneapolis, MN USA Univ Minnesota, Minneapolis, MN USAHoang, Tien论文数: 0 引用数: 0 h-index: 0机构: Univ Minnesota, Minneapolis, MN USA Univ Minnesota, Minneapolis, MN USAMeyers, Paul论文数: 0 引用数: 0 h-index: 0机构: Univ Minnesota, Minneapolis, MN USA Univ Minnesota, Minneapolis, MN USA
- [23] A phase I study evaluating the safety, efficacy, pharmacokinetics and pharmacodynamics of AL3810 in advanced solid tumorsANNALS OF ONCOLOGY, 2015, 26 : 37 - 37Cao, J.论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R ChinaLi, J.论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R ChinaJi, D.论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R ChinaShen, W.论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R ChinaJiang, L.论文数: 0 引用数: 0 h-index: 0机构: ShangHai HaiHe Pharmaceut, Shanghai, Peoples R China Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R ChinaMa, X.论文数: 0 引用数: 0 h-index: 0机构: ShangHai HaiHe Pharmaceut, Shanghai, Peoples R China Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R ChinaPang, J.论文数: 0 引用数: 0 h-index: 0机构: ShangHai HaiHe Pharmaceut, Shanghai, Peoples R China Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R ChinaKanehisa, A.论文数: 0 引用数: 0 h-index: 0机构: IRIS, Suresnes, France Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R ChinaLegrand, F.论文数: 0 引用数: 0 h-index: 0机构: IRIS, PIT Oncol, Suresnes, France Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R ChinaPallis, A.论文数: 0 引用数: 0 h-index: 0机构: IRIS, Suresnes, France Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R ChinaPaux, G.论文数: 0 引用数: 0 h-index: 0机构: IRIS, Suresnes, France Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R ChinaRobert, R.论文数: 0 引用数: 0 h-index: 0机构: IRIS, Suresnes, France Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R ChinaChen, X.论文数: 0 引用数: 0 h-index: 0机构: Int Ctr Therapeut Res Servier, ICTR, Beijing, Peoples R China Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R ChinaLetecheur, P.论文数: 0 引用数: 0 h-index: 0机构: Int Ctr Therapeut Res Servier, ICTR, Beijing, Peoples R China Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R ChinaQiang, L.论文数: 0 引用数: 0 h-index: 0机构: Int Ctr Therapeut Res Servier, ICTR, Beijing, Peoples R China Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R ChinaDing, J.论文数: 0 引用数: 0 h-index: 0机构: Shanghai Intsitute Mat Med, Shanghai, Peoples R China Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China
- [24] Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumorsCancer Chemotherapy and Pharmacology, 2009, 63 : 1065 - 1071Chia-Chi Lin论文数: 0 引用数: 0 h-index: 0机构: Cancer Therapy and Research Center,Institute for Drug DevelopmentEmiliano Calvo论文数: 0 引用数: 0 h-index: 0机构: Cancer Therapy and Research Center,Institute for Drug DevelopmentKyriakos P. Papadopoulos论文数: 0 引用数: 0 h-index: 0机构: Cancer Therapy and Research Center,Institute for Drug DevelopmentAmita Patnaik论文数: 0 引用数: 0 h-index: 0机构: Cancer Therapy and Research Center,Institute for Drug DevelopmentJohn Sarantopoulos论文数: 0 引用数: 0 h-index: 0机构: Cancer Therapy and Research Center,Institute for Drug DevelopmentAlain C. Mita论文数: 0 引用数: 0 h-index: 0机构: Cancer Therapy and Research Center,Institute for Drug DevelopmentGlenn G. Preston论文数: 0 引用数: 0 h-index: 0机构: Cancer Therapy and Research Center,Institute for Drug DevelopmentMonica M. Mita论文数: 0 引用数: 0 h-index: 0机构: Cancer Therapy and Research Center,Institute for Drug DevelopmentJordi Rodon论文数: 0 引用数: 0 h-index: 0机构: Cancer Therapy and Research Center,Institute for Drug DevelopmentTheresa Mays论文数: 0 引用数: 0 h-index: 0机构: Cancer Therapy and Research Center,Institute for Drug DevelopmentI-Tien Yeh论文数: 0 引用数: 0 h-index: 0机构: Cancer Therapy and Research Center,Institute for Drug DevelopmentPat O’Rourke论文数: 0 引用数: 0 h-index: 0机构: Cancer Therapy and Research Center,Institute for Drug DevelopmentChris H. Takimoto论文数: 0 引用数: 0 h-index: 0机构: Cancer Therapy and Research Center,Institute for Drug DevelopmentJanet E. Dancey论文数: 0 引用数: 0 h-index: 0机构: Cancer Therapy and Research Center,Institute for Drug DevelopmentHelen Chen论文数: 0 引用数: 0 h-index: 0机构: Cancer Therapy and Research Center,Institute for Drug DevelopmentAnthony W. Tolcher论文数: 0 引用数: 0 h-index: 0机构: Cancer Therapy and Research Center,Institute for Drug Development
- [25] Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumorsCANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 1065 - 1071Lin, Chia-Chi论文数: 0 引用数: 0 h-index: 0机构: Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USACalvo, Emiliano论文数: 0 引用数: 0 h-index: 0机构: Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USAPapadopoulos, Kyriakos P.论文数: 0 引用数: 0 h-index: 0机构: Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USAPatnaik, Amita论文数: 0 引用数: 0 h-index: 0机构: Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USASarantopoulos, John论文数: 0 引用数: 0 h-index: 0机构: Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USAMita, Alain C.论文数: 0 引用数: 0 h-index: 0机构: Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USAPreston, Glenn G.论文数: 0 引用数: 0 h-index: 0机构: Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USAMita, Monica M.论文数: 0 引用数: 0 h-index: 0机构: Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USARodon, Jordi论文数: 0 引用数: 0 h-index: 0机构: Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USAMays, Theresa论文数: 0 引用数: 0 h-index: 0机构: Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USAYeh, I-Tien论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USAO'Rourke, Pat论文数: 0 引用数: 0 h-index: 0机构: Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USATakimoto, Chris H.论文数: 0 引用数: 0 h-index: 0机构: Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USADancey, Janet E.论文数: 0 引用数: 0 h-index: 0机构: NCI, Canc Therapy Evaluat Program, Rockville, MD USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USAChen, Helen论文数: 0 引用数: 0 h-index: 0机构: NCI, Canc Therapy Evaluat Program, Rockville, MD USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USATolcher, Anthony W.论文数: 0 引用数: 0 h-index: 0机构: Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA Canc Therapy & Res Ctr S Texas, Inst Drug Dev, San Antonio, TX 78229 USA
- [26] Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumoursEUROPEAN JOURNAL OF CANCER, 2017, 81 : 81 - 89Hollebecque, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, France Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, FranceBahleda, R.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, France Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, FranceFaivre, L.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Saclay, Gustave Roussy, Serv Biostat & Epidemiol, F-94805 Villejuif, France Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, FranceAdam, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Saclay, Gustave Roussy, Dept Biol & Pathol Med, F-94805 Villejuif, France Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, FrancePoinsignon, V.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Saclay, Gustave Roussy, Pharmacol & Drug Anal Dept, F-94805 Villejuif, France Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, FrancePaci, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Saclay, Gustave Roussy, Pharmacol & Drug Anal Dept, F-94805 Villejuif, France Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, FranceGomez-Roca, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, France Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, FranceThery, J. C.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 06, Dept Med Oncol, Univ Hosp Pitie Salpetriere, Paris, France Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, FranceLe Deley, M. C.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Saclay, Gustave Roussy, Serv Biostat & Epidemiol, F-94805 Villejuif, France Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, FranceVarga, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, France Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, FranceGazzah, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, France Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, FranceIleana, E.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, France Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, FranceGharib, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Saclay, Gustave Roussy, Dept Biol & Pathol Med, F-94805 Villejuif, France Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, FranceAngevin, E.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, France Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, FranceMalekzadeh, K.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Saclay, Gustave Roussy, Serv Biostat & Epidemiol, F-94805 Villejuif, France Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, France论文数: 引用数: h-index:机构:Soria, J. C.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, France Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, FranceSpano, J. P.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 06, Dept Med Oncol, Univ Hosp Pitie Salpetriere, Paris, France Univ Paris Saclay, Gustave Roussy, Drug Dev Dept, F-94805 Villejuif, France
- [27] A phase I study of the safety, tolerability and pharmacokinetics of pazopanib (P) in combination with gemcitabine (G) for advanced solid tumorsEJC SUPPLEMENTS, 2010, 8 (07): : 25 - 25Richly, H.论文数: 0 引用数: 0 h-index: 0机构: Univ Essen Gesamthsch, W German Canc Ctr, Essen, Germany Univ Essen Gesamthsch, W German Canc Ctr, Essen, GermanyRubin, S. D.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline Inc, Oncol, Collegeville, PA USA Univ Essen Gesamthsch, W German Canc Ctr, Essen, GermanyMadi, A.论文数: 0 引用数: 0 h-index: 0机构: No Ctr Canc Care, Newcastle, NSW, Australia Univ Essen Gesamthsch, W German Canc Ctr, Essen, GermanyJeffels, M.论文数: 0 引用数: 0 h-index: 0机构: No Ctr Canc Care, Newcastle, NSW, Australia Univ Essen Gesamthsch, W German Canc Ctr, Essen, GermanyNokay, B.论文数: 0 引用数: 0 h-index: 0机构: Univ Essen Gesamthsch, W German Canc Ctr, Essen, Germany Univ Essen Gesamthsch, W German Canc Ctr, Essen, GermanyGibson, D.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline Inc, Oncol, Collegeville, PA USA Univ Essen Gesamthsch, W German Canc Ctr, Essen, GermanyWeller, S.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline Inc, Res Triangle Pk, NC USA Univ Essen Gesamthsch, W German Canc Ctr, Essen, GermanyScheulen, M. E.论文数: 0 引用数: 0 h-index: 0机构: Univ Essen Gesamthsch, W German Canc Ctr, Essen, Germany Univ Essen Gesamthsch, W German Canc Ctr, Essen, GermanyPlummer, R.论文数: 0 引用数: 0 h-index: 0机构: No Ctr Canc Care, Newcastle, NSW, Australia Univ Essen Gesamthsch, W German Canc Ctr, Essen, Germany
- [28] A phase I trial of RAD001 in combination with cetuximab in patients with advanced solid tumorsJOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)Avadhani, A. N.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USA Univ Penn, Philadelphia, PA 19104 USAFlaherty, K.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USA Univ Penn, Philadelphia, PA 19104 USARosen, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USA Univ Penn, Philadelphia, PA 19104 USAVeronese, M. L.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USA Univ Penn, Philadelphia, PA 19104 USAHarlacker, K.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USA Univ Penn, Philadelphia, PA 19104 USAJohnson, S. W.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USA Univ Penn, Philadelphia, PA 19104 USASherman, E.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USA Univ Penn, Philadelphia, PA 19104 USAGriggs, W.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USA Univ Penn, Philadelphia, PA 19104 USADivgi, C. R.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USA Univ Penn, Philadelphia, PA 19104 USAO'Dwyer, P. J.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Philadelphia, PA 19104 USA Univ Penn, Philadelphia, PA 19104 USA
- [29] Safety and efficacy of copanlisib in combination with nivolumab: A phase Ib study in patients with advanced solid tumorsMOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)Carneiro, Benedito A.论文数: 0 引用数: 0 h-index: 0Jotte, Robert论文数: 0 引用数: 0 h-index: 0Gabrail, Nashat论文数: 0 引用数: 0 h-index: 0Hamid, Omid论文数: 0 引用数: 0 h-index: 0Huang, Funan论文数: 0 引用数: 0 h-index: 0Chaturvedi, Shalini论文数: 0 引用数: 0 h-index: 0Herpers, Matthias论文数: 0 引用数: 0 h-index: 0Soler, Lidia Mongay论文数: 0 引用数: 0 h-index: 0Childs, Barrett H.论文数: 0 引用数: 0 h-index: 0Hansen, Aaron论文数: 0 引用数: 0 h-index: 0
- [30] Safety and Efficacy of Copanlisib in Combination with Nivolumab: A Phase Ib Study in Patients with Advanced Solid TumorsCANCER RESEARCH COMMUNICATIONS, 2025, 5 (03): : 444 - 457Carneiro, Benedito A.论文数: 0 引用数: 0 h-index: 0机构: Brown Univ, Lifespan Canc Inst, Legorreta Canc Ctr, Providence, RI USA Brown Univ, Lifespan Canc Inst, Legorreta Canc Ctr, Providence, RI USAJotte, Robert M.论文数: 0 引用数: 0 h-index: 0机构: Rocky Mt Canc Ctr, Denver, CO USA US Oncol Res, Houston, TX USA Brown Univ, Lifespan Canc Inst, Legorreta Canc Ctr, Providence, RI USAGabrail, Nashat Y.论文数: 0 引用数: 0 h-index: 0机构: Gabrail Canc & Res Ctr, Canton, OH USA Brown Univ, Lifespan Canc Inst, Legorreta Canc Ctr, Providence, RI USAWentzel, Kristopher论文数: 0 引用数: 0 h-index: 0机构: Cedars Sinai Affiliate, Angeles Clin & Res Inst, Los Angeles, CA USA Brown Univ, Lifespan Canc Inst, Legorreta Canc Ctr, Providence, RI USAHuang, Funan论文数: 0 引用数: 0 h-index: 0机构: Bayer Healthcare Pharmaceut Inc, Whippany, NJ USA Brown Univ, Lifespan Canc Inst, Legorreta Canc Ctr, Providence, RI USAChaturvedi, Shalini论文数: 0 引用数: 0 h-index: 0机构: Bayer Healthcare Pharmaceut Inc, Whippany, NJ USA Brown Univ, Lifespan Canc Inst, Legorreta Canc Ctr, Providence, RI USAWeispfenning, Anke论文数: 0 引用数: 0 h-index: 0机构: Bayer AG, Pharmaceut Div, Berlin, Germany Brown Univ, Lifespan Canc Inst, Legorreta Canc Ctr, Providence, RI USAHiemeyer, Florian论文数: 0 引用数: 0 h-index: 0机构: Bayer AG, Pharmaceut Div, Berlin, Germany Brown Univ, Lifespan Canc Inst, Legorreta Canc Ctr, Providence, RI USAMorcos, Peter N.论文数: 0 引用数: 0 h-index: 0机构: Bayer Healthcare Pharmaceut Inc, Whippany, NJ USA Brown Univ, Lifespan Canc Inst, Legorreta Canc Ctr, Providence, RI USASoler, Lidia Mongay论文数: 0 引用数: 0 h-index: 0机构: Bayer Healthcare Pharmaceut Inc, Whippany, NJ USA Brown Univ, Lifespan Canc Inst, Legorreta Canc Ctr, Providence, RI USAChilds, Barrett H.论文数: 0 引用数: 0 h-index: 0机构: Bayer Healthcare Pharmaceut Inc, Whippany, NJ USA Brown Univ, Lifespan Canc Inst, Legorreta Canc Ctr, Providence, RI USAHansen, Aaron R.论文数: 0 引用数: 0 h-index: 0机构: Princess Margaret Canc Ctr, Toronto, ON, Canada Brown Univ, Lifespan Canc Inst, Legorreta Canc Ctr, Providence, RI USA